MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling
2017 · Biomedicine & Pharmacotherapy · 33 citations
https://doi.org/10.1016/j.biopha.2017.08.143
R
Ranran Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
635
Citations
16
h-index
22
i10-index
Ranran Kong is an academic researcher from Jiangsu Food and Pharmaceutical Science College. The author has contributed to research in topics: RNA modifications and cancer & Lung Cancer Research Studies & MicroRNA in disease regulation. The author has an h-index of 16, co-authored 56 publications.
ORCID: 0000-0002-3658-8745Papers by this author
worksTranscriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer
2022 · American Journal of Respiratory and Critical Care Medicine · 23 citations
https://doi.org/10.1164/rccm.202110-2358oc
Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion
2015 · PLoS ONE · 16 citations
https://doi.org/10.1371/journal.pone.0142815
Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis
2024 · Renal Failure · 6 citations
https://doi.org/10.1080/0886022x.2024.2365408
Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer
2025 · Journal of Hematology & Oncology · 3 citations
https://doi.org/10.1186/s13045-025-01667-5
March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins
2025 · Inflammation · 2 citations
https://doi.org/10.1007/s10753-025-02319-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat